Immunotherapy combination generates responses against castration-resistant metastatic prostate cancer
(University of Texas M. D. Anderson Cancer Center) Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical...